A metastatic breast cancer drug, discovered in the McDonnell Lab, is now FDA-approved—the first new oral endocrine therapy in 20+ years. Another might not be so far behind.
The hybrid retreat showcased the latest gastric cancer, blood cancer, pediatric sarcoma, glioblastoma, breast cancer, and immune micro-environment research.
For the first time in three years, cancer patients, survivors, families, friends, clinicians, faculty, and staff gathered in person for the Tree of Hope.
"What's Best For Breasts? A Conversation with Clinicians" was held online, Oct. 8. Topics included imaging, genetic testing, breast cancer risk, research, survivorship, and more.
A research team led by Ann Marie Pendergast, PhD, found, in animal studies, that a leukemia drug disrupted HER2-positive breast cancer-spread to the brain.
John Wayne Cancer Foundation is funding research by breast surgical oncologist Maggie DiNome, MD, to create a molecular-based way to predict cancer spread to lymph nodes.
DCI study led by Gayathri Devi, PhD, finds chronic stresses such as racism and poverty alter cellular functions that promote tumor growth and proliferation
Donald McDonnell, PhD, associate director for Translational Research, DCI, receives prestigious St. Patrick's Day Irish science medal for contributions to academia and industry.
For Melinda Rittenhouse, an MBC survivor & member of an artists' collective that recently exhibited their work at Duke Hospital, the fact it was here "meant even more."
Susan Dent, MD, FRCPC, associate director, Clinical Research, DCI Breast Cancer Disease Group, has joined the Duke IBC Consortium as clinical director.
The grandfather of breast surgical oncologist Hannah Woriax, MD, was the first Native American to graduate from the Duke Med School and train in Family Medicine.
On Feb. 2 at noon, the Southeastern American Indian Cancer Health Equity Partnership hosts DCI breast surgeon Hannah Woriax, MD, for a virtual lecture (with CME credit available).
The burden of care after breast cancer treatment is on oncologists, other specialists & primary care providers. Here's a new Duke-edited guide for treating survivors.
In October, the DCI Office of Health Equity & the Mexican Consulate in Raleigh brought awareness to breast, uterine, and cervical cancer detection and prevention.
Former Blue Devil Maggie DiNome, MD, a breast surgical oncologist, joined Duke from UCLA as medical director of Wake County Breast Cancer Services and as a professor of Surgery.
Haley Moss, MD, MBA, will work to expand access to care for women veterans through teleoncology and clinical trials in new role at the U.S. Dept. of Veterans Affairs.
A DCI breast cancer care team joins forces with a genetics counselor to treat mother with high-risk genetic syndrome; prompting testing and preventative screening for her kids.
The metastatic breast cancer research grants, made possible by Susan G. Komen, bring together patient advocates and DCI & UNC Lineberger investigators.
"What's Best For Breasts? A Conversation with Duke Clinicians" was held online on Oct. 2. Topics included imaging, genetic testing, breast cancer risk assessment & prevention.
For Breast Cancer Awareness Month, Duke Women's Cancer Care Raleigh to host community event with mammograms and activities centered on women's health, Oct. 9.